Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Patient room to be created on Ben-my-Chree
Summerland: Survivors and relatives vow to continue campaign to overturn inquest verdict
Mona Street residents meeting 'very productive', says Peel Commissioners
Man who touched himself on bus jailed